Effect of α-tocopherol on LDL oxidation and glycation

In vitro and in vivo studies

Dai Li, Sridevi Devaraj, Cindy Fuller, Richard Bucala, Ishwarlal Jialal

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Much data support a role for both low density lipoprotein (LDL) oxidation and glycation in atherogenesis. While α-tocopherol decreases the oxidative susceptibility of LDL, its role in decreasing LDL glycation is unclear. Hence we tested the effect of α-tocopherol both in vitro and in vivo on LDL oxidation and glycation. LDL was isolated after enrichment of plasma with α-tocopherol. This resulted in a 2-fold increase in α- tocopherol in LDL (AT-LDL). During a 6-day incubation of control LDL (C-LDL) and AT-LDL with 25 mM glucose, there were no significant differences in the degree of glycation on days 1, 3, and 6. Also, apoB advanced glycosylation end product levels were not significantly different between C-LDL and AT- LDL. There was a progressive increase in the susceptibility of LDL to oxidation with increasing LDL glycation as evidenced by reduced lag time of copper-catalyzed LDL oxidation. However, AT-LDL, was more resistant to copper-catalyzed oxidation. Similar findings were observed when the LDLs were incubated with endothelial cells. The data from the α-tocopherol supplementation study confirmed our in vitro findings that α-tocopherol significantly decreases oxidative susceptibility of LDL, but does not affect its glycation. Therefore, while glycation increases LDL oxidative susceptibility, α-tocopherol decreases the oxidation of glycated LDL but not LDL glycation.

Original languageEnglish (US)
Pages (from-to)1978-1986
Number of pages9
JournalJournal of Lipid Research
Volume37
Issue number9
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

Tocopherols
LDL Lipoproteins
Oxidation
In Vitro Techniques
Copper
Advanced Glycosylation End Products
Endothelial cells
Apolipoproteins B

Keywords

  • advanced glycosylation end products

ASJC Scopus subject areas

  • Endocrinology

Cite this

Li, D., Devaraj, S., Fuller, C., Bucala, R., & Jialal, I. (1996). Effect of α-tocopherol on LDL oxidation and glycation: In vitro and in vivo studies. Journal of Lipid Research, 37(9), 1978-1986.

Effect of α-tocopherol on LDL oxidation and glycation : In vitro and in vivo studies. / Li, Dai; Devaraj, Sridevi; Fuller, Cindy; Bucala, Richard; Jialal, Ishwarlal.

In: Journal of Lipid Research, Vol. 37, No. 9, 09.1996, p. 1978-1986.

Research output: Contribution to journalArticle

Li, D, Devaraj, S, Fuller, C, Bucala, R & Jialal, I 1996, 'Effect of α-tocopherol on LDL oxidation and glycation: In vitro and in vivo studies', Journal of Lipid Research, vol. 37, no. 9, pp. 1978-1986.
Li D, Devaraj S, Fuller C, Bucala R, Jialal I. Effect of α-tocopherol on LDL oxidation and glycation: In vitro and in vivo studies. Journal of Lipid Research. 1996 Sep;37(9):1978-1986.
Li, Dai ; Devaraj, Sridevi ; Fuller, Cindy ; Bucala, Richard ; Jialal, Ishwarlal. / Effect of α-tocopherol on LDL oxidation and glycation : In vitro and in vivo studies. In: Journal of Lipid Research. 1996 ; Vol. 37, No. 9. pp. 1978-1986.
@article{36a270f525b044f7b47deeec222cb3c7,
title = "Effect of α-tocopherol on LDL oxidation and glycation: In vitro and in vivo studies",
abstract = "Much data support a role for both low density lipoprotein (LDL) oxidation and glycation in atherogenesis. While α-tocopherol decreases the oxidative susceptibility of LDL, its role in decreasing LDL glycation is unclear. Hence we tested the effect of α-tocopherol both in vitro and in vivo on LDL oxidation and glycation. LDL was isolated after enrichment of plasma with α-tocopherol. This resulted in a 2-fold increase in α- tocopherol in LDL (AT-LDL). During a 6-day incubation of control LDL (C-LDL) and AT-LDL with 25 mM glucose, there were no significant differences in the degree of glycation on days 1, 3, and 6. Also, apoB advanced glycosylation end product levels were not significantly different between C-LDL and AT- LDL. There was a progressive increase in the susceptibility of LDL to oxidation with increasing LDL glycation as evidenced by reduced lag time of copper-catalyzed LDL oxidation. However, AT-LDL, was more resistant to copper-catalyzed oxidation. Similar findings were observed when the LDLs were incubated with endothelial cells. The data from the α-tocopherol supplementation study confirmed our in vitro findings that α-tocopherol significantly decreases oxidative susceptibility of LDL, but does not affect its glycation. Therefore, while glycation increases LDL oxidative susceptibility, α-tocopherol decreases the oxidation of glycated LDL but not LDL glycation.",
keywords = "advanced glycosylation end products",
author = "Dai Li and Sridevi Devaraj and Cindy Fuller and Richard Bucala and Ishwarlal Jialal",
year = "1996",
month = "9",
language = "English (US)",
volume = "37",
pages = "1978--1986",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "9",

}

TY - JOUR

T1 - Effect of α-tocopherol on LDL oxidation and glycation

T2 - In vitro and in vivo studies

AU - Li, Dai

AU - Devaraj, Sridevi

AU - Fuller, Cindy

AU - Bucala, Richard

AU - Jialal, Ishwarlal

PY - 1996/9

Y1 - 1996/9

N2 - Much data support a role for both low density lipoprotein (LDL) oxidation and glycation in atherogenesis. While α-tocopherol decreases the oxidative susceptibility of LDL, its role in decreasing LDL glycation is unclear. Hence we tested the effect of α-tocopherol both in vitro and in vivo on LDL oxidation and glycation. LDL was isolated after enrichment of plasma with α-tocopherol. This resulted in a 2-fold increase in α- tocopherol in LDL (AT-LDL). During a 6-day incubation of control LDL (C-LDL) and AT-LDL with 25 mM glucose, there were no significant differences in the degree of glycation on days 1, 3, and 6. Also, apoB advanced glycosylation end product levels were not significantly different between C-LDL and AT- LDL. There was a progressive increase in the susceptibility of LDL to oxidation with increasing LDL glycation as evidenced by reduced lag time of copper-catalyzed LDL oxidation. However, AT-LDL, was more resistant to copper-catalyzed oxidation. Similar findings were observed when the LDLs were incubated with endothelial cells. The data from the α-tocopherol supplementation study confirmed our in vitro findings that α-tocopherol significantly decreases oxidative susceptibility of LDL, but does not affect its glycation. Therefore, while glycation increases LDL oxidative susceptibility, α-tocopherol decreases the oxidation of glycated LDL but not LDL glycation.

AB - Much data support a role for both low density lipoprotein (LDL) oxidation and glycation in atherogenesis. While α-tocopherol decreases the oxidative susceptibility of LDL, its role in decreasing LDL glycation is unclear. Hence we tested the effect of α-tocopherol both in vitro and in vivo on LDL oxidation and glycation. LDL was isolated after enrichment of plasma with α-tocopherol. This resulted in a 2-fold increase in α- tocopherol in LDL (AT-LDL). During a 6-day incubation of control LDL (C-LDL) and AT-LDL with 25 mM glucose, there were no significant differences in the degree of glycation on days 1, 3, and 6. Also, apoB advanced glycosylation end product levels were not significantly different between C-LDL and AT- LDL. There was a progressive increase in the susceptibility of LDL to oxidation with increasing LDL glycation as evidenced by reduced lag time of copper-catalyzed LDL oxidation. However, AT-LDL, was more resistant to copper-catalyzed oxidation. Similar findings were observed when the LDLs were incubated with endothelial cells. The data from the α-tocopherol supplementation study confirmed our in vitro findings that α-tocopherol significantly decreases oxidative susceptibility of LDL, but does not affect its glycation. Therefore, while glycation increases LDL oxidative susceptibility, α-tocopherol decreases the oxidation of glycated LDL but not LDL glycation.

KW - advanced glycosylation end products

UR - http://www.scopus.com/inward/record.url?scp=0029792866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029792866&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 1978

EP - 1986

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 9

ER -